Endothelin-1-induced contraction of pulmonary arteries from endotoxemic rats is attenuated by the endothelin-A receptor antagonist, BQ123

被引:19
作者
Curzen, NP [1 ]
Mitchell, JA [1 ]
Jourdan, KB [1 ]
Griffiths, MJD [1 ]
Evans, TW [1 ]
机构
[1] NATL HEART & LUNG INST, LONDON, ENGLAND
关键词
endothelin-1; sepsis; pulmonary artery; endothelin-A receptor antagonist; BQ123; sarafotoxin S6c; nitric oxide; lipopolysaccharide; vascular biology; endothelium; thromboxane;
D O I
10.1097/00003246-199612000-00013
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objective: Sepsis is characterized by systemic vasodilation and hyporesponsiveness to constrictor agents, at a time when the pulmonary circulation exhibits varying degrees of vasoconstriction. Plasma endothelin-1 concentrations are increased, but the role of this potent vasoconstrictor peptide in modulating the vas vascular response to sepsis is unknown. Therefore, we assessed the effect of endothelin-A receptor antagonism in the response of pulmonary arteries from rats treated with lipopolysaccharide to endothelin-1, and determined the vasomotor role of the endothelin-B receptors that are known to be located on rat pulmonary artery smooth muscle and endothelium. Design: Prospective, controlled study. Setting: Animal research laboratory. Subjects: Male Wistar rats (275 to 300 g). Interventions: Animals were injected with either lipopolysaccharide (20 mg/kg ip) or saline (1 mL ip) 4 hrs before being killed. The main pulmonary arteries were cut into 2-mm rings, and suspended in an organ bath. In the first set of experiments, half of the rings underwent a procedure that removed the endothelium, and the contractile response to cumulative doses of endothelin-1 (10(-11) to 10(-6) M) was measured. Half of the rings were pretreated with the endothelin-A receptor antagonist, BQ123 (10(-5) M or 10(-6) M), and the other half of the rings were treated with vehicle. In a separate group of experiments, the contractile response to cumulative concentrations of the selective endothelin B agonist, sarafotoxin S6c (10(-11) to 10(-6) M), was measured in rings at baseline tension. Second, the possible dilator effect of endothelin-B receptor activation was tested by the administration of sarafotoxin S6c (10(-7) to 10(-6) M) to rings preconstricted by 10(-6) M of U46619, a thromboxane receptor agonist, either in the presence or absence of the nitric oxide synthase inhibitor, N-omega-nitro-L-arginine-methylester (10(-4) M). Acetylcholine-induced (10(-4) M), endothelium-dependent vasodilation was also measured. Measurements and Main Results: BQ123 (10(-5) or 10(-6) M) caused consecutive rightward shifts in the endothelin-1 concentration-contraction curves for all ring types, including the intact rings from endotoxemic animals. Sarafotoxin S6c failed to induce any direct constriction in rings from sham-treated or lipopolysaccharide treated rats. However, sarafotoxin S6c induced transient vasodilation at the initial dose in rings from sham-treated rats but not lipopolysaccharide treated rats-an effect that was attenuated by N-omega-nitro-L-arginine-methylester. Acetylcholine induced an N-omega-nitro-L-arginine-methylester-sensitive vasodilation that was reduced in rings from endotoxin-treated rats. Conclusions: Endothelin-A receptor blockade is an effective means of attenuating endothelin-1 induced contraction of isolated pulmonary artery rings, even from rats rendered endotoxemic. Endothelin-B receptors on the pulmonary artery cause vasodilation via the release of nitric oxide, and have no constrictor component. The functional effects of endothelin-B receptors on tone are lost after lipopolysaccharide treatment. The endothelium is involved in both the constrictor and dilator effects of endothelin in rat pulmonary artery, confirming a pivotal role for endothelial cells in the vascular response to sepsis.
引用
收藏
页码:2007 / 2013
页数:7
相关论文
共 30 条
  • [1] CLONING AND EXPRESSION OF A CDNA-ENCODING AN ENDOTHELIN RECEPTOR
    ARAI, H
    HORI, S
    ARAMORI, I
    OHKUBO, H
    NAKANISHI, S
    [J]. NATURE, 1990, 348 (6303) : 730 - 732
  • [2] THE CURRENT ENDOTHELIN RECEPTOR CLASSIFICATION - TIME FOR RECONSIDERATION
    BAX, WA
    SAXENA, PR
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1994, 15 (10) : 379 - 386
  • [3] THE ENDOTHELIN ET(B) RECEPTOR MEDIATES BOTH VASODILATION AND VASOCONSTRICTION INVIVO
    CLOZEL, M
    GRAY, GA
    BREU, V
    LOFFLER, BM
    OSTERWALDER, R
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 186 (02) : 867 - 873
  • [4] ROLE OF THE ENDOTHELIUM IN MODULATING THE VASCULAR-RESPONSE TO SEPSIS
    CURZEN, NP
    GRIFFITHS, MJD
    EVANS, TW
    [J]. CLINICAL SCIENCE, 1994, 86 (04) : 359 - 374
  • [5] CURZEN NP, 1995, BRIT HEART J, V73, pP46
  • [6] CURZEN NP, 1995, AM J PHYSIOL, V37, pH2260
  • [7] DENUCCI G, 1988, P NATL ACAD SCI USA, V85, P9797
  • [8] DILATOR EFFECT OF ENDOTHELINS IN PULMONARY CIRCULATION - CHANGES ASSOCIATED WITH CHRONIC HYPOXIA
    EDDAHIBI, S
    SPRINGALL, D
    MANNAN, M
    CARVILLE, C
    CHABRIER, PE
    LEVAME, M
    RAFFESTIN, B
    POLAK, J
    ADNOT, S
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 265 (06): : L571 - L580
  • [9] A NEW LOOK AT THE PULMONARY CIRCULATION IN ACUTE LUNG INJURY
    FOX, GA
    MCCORMACK, DG
    [J]. THORAX, 1992, 47 (09) : 743 - 747
  • [10] IN-VIVO TREATMENT WITH ENDOTOXIN INDUCES NITRIC-OXIDE SYNTHASE IN RAT MAIN PULMONARY-ARTERY
    GRIFFITHS, MJD
    LIU, S
    CURZEN, NP
    MESSENT, M
    EVANS, TW
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1995, 268 (03) : L509 - L518